Before the introduction of adrenergic blocking agents and pressor substances operative removal of a phaeochromocytoma was a hazardous procedure, with a mortality of up to 25% (Graham, 1951). A mortality of 50% has been reported in operations on patients with unsuspected turnours (Apgar and Papper, 1951 ; Riddell, Schull, Frist, and Baker, 1963 
Before the introduction of adrenergic blocking agents and pressor substances operative removal of a phaeochromocytoma was a hazardous procedure, with a mortality of up to 25% (Graham, 1951) . A mortality of 50% has been reported in operations on patients with unsuspected turnours (Apgar and Papper, 1951 ; Riddell, Schull, Frist, and Baker, 1963) . The dangers were hypertensive crises after induction of anaesthesia, extreme fluctuations of blood pressure during the surgeon's handling of the tumour, sudden hypotension which immediately followed removal of the tumour, arrhythmias from sudden release of large concentrations of sympathomimetic amines, coupled with sensitization of the myocardium to production of arrhythmias by the anaesthetic agent. Complications tended to be more prominent in patients with sustained hypertension.
The use of antagonists of adrenergic a-receptors (" ablockers ") such as phentolamine or phenoxybenzamine permits control over fluctuations of the blood pressure. The effects of catecholamines on the heart rate and rhythm are, however, unaltered because a-blockers have no influence on adrenergic /3-receptors. These effects can be controlled by f-receptor antagonists (" fl-blockers ") such as pronethalol and propranolol. This paper details our experience with the use of various adrenergic blocking agents in the operative management of 27 patients with phaeochromocytoma on 30 occasions and traces the evolution of a therapeutic programme designed to modify the effects of catecholamines on a-and f-receptors and so ensure safer anaesthetic and operative procedures.
Use of a-adrenergic Blocking Agents to Control
Blood Pressure 1. Phentolame
In the first 13 patients operated on in this hospital for removal of a phaeochromocytoma, no preoperative preparation was given with either a-or /3-receptor antagonists. Papaveretum and hyoscine were usually used for premedication. Control of blood pressure after induction and during dissection and removal of the tumour was attempted by the use of repeated intravenous injections of phentolamine, 2.5 or 5 mg., into the rubber tubing of an intravenous infusion of normal saline. half an hour until control of the blood pressure could be obtained with intravenous phentolamine; in all, over 100 mg. of phentolamine was given. After resection of the tumour, which was incomplete, infusion with noradrenaline was necessary for four hours to maintain the systolic blood pressure at 100. After operation his diabetes was controlled by diet alone, but in 1958 symptoms of sweating, thirst, and polyuria recurred and pressor amines reappeared in the urine. Laparetomy failed to reveal any tumour in the abdominal cavity. His hypertension was then treated with oral phenoxybenzamine, 60 mg./day, and his diabetes with 20 units of insulin zinc suspension. Hypertension, diabetes, and symptoms of anxiety and sweating were well controlled until 1963, when attacks of sweating recurred. He was reinvestigated at this time, but x-ray examination failed to locate the tumour and he was submitted to a further laparotomy. Details of this operation are given below (Case 4).
Case 2
An 18-year-old meat porter with a five-year history of headaches was transferred from King's College Hospital (Dr. J. L. Livingstone) for investigation of hypertension. At operation (by Mr. D. R. Davies) an extra-adrenal phaeochromocytonma was found at the hilum of the left kidney, which was ischaemic. Further details have been given by Rosenheim, Ross, Wrong, Hodson, Davies, and Smith (1963) .
Premedication was with pethidine 50 mg., promethazine 50 mg., and hyoscine 0.4 mg. The pulse rate was 70/min. before induction of anaesthesia, rose to 150 during induction (with thiopentone, tubocurarine, nitrous oxide, and oxygen), then fell to 90-110 during handling of the tumour, when the blood pressure rose from 190/ 130 to 260+/170 mm. Hg. Phentolamine was then given and the pulse rate immediately rose to 160, falling to 110 as the effect of the phentolamine subsided. Bleeding was very slight, and only 1 pint (570 ml.) of blood was given.
Before the diagnosis of phaeochromocytoma was suspected a perfemoral aortogram was performed under general anaesthesia (thiopentone, suxamethonium, nitrous oxide, and oxygen). Since the blood pressure was high, 5 mg. of a ganglion-blocking agent, trimetaphan (Arfonad), was given. This produced gross cardiac arrhythmias. The aortogram showed the presence of a tumour compressing the left renal artery.
Case 2 is reported to show the tachycardia that can be produced by phentolamine in a patient with a predominantly noradrenaline-secreting extra-adrenal tumour, and also to illustrate the dangers of giving a ganglion-blocking drug, trimetaphan, in these circumstances.
Phenoxybenzamine
Greatly improved control has been achieved by the use of phenoxybenzamine (Dibenzyline, Dibenyline). This substance has a much longer duration of action than phentolamine. In the first patient to whom it was given (Case 3) the Since the tumour had not been located before operation, an amount of phenoxybenzamine below that required for complete sympathetic blockade was deliberately given so that palpation of the tumour by the surgeon would still produce a rise of blood pressure. Though severe hypertension developed during the operation, comparison of Figs. 1 and 3 shows that the violent swings of blood pressure encountered when phentolamine was used as the adrenergic blocking agent were absent when phenoxybenzamine was given. Control of the pulse rate was also good, except when there was bleeding or when the test dose of phentolamine was given. Noradrenaline was not required after the small tumours had been removed; other seedling tumours remained in this patient. The blood pressure rose slightly on induction but then fell to 90/60, rising again to 250/150 as the tumour was dissected (Fig. 4) . There was a brisk haemorrhage during the dissection; tht blood pressure fell to 110/70. The pulse rate was 100/min. at induction, fell to 60-70 during dissection of the tumour, but rose to 150 immediately after the haemorrhage. Extrasystoles and left bundlebranch block appeared at this time, but disappeared with the rapid transfusion of 3 pints (1.7 litres) of blood. After excision of the tumour the blood pressure fell to 90/70, but rose to 110/80 with transfusion of a further pint (570 ml.) of blood. Noradrenaline was not required. During the operation 6 pints (3.4 litres) of blood and 3 pints (1.7 litres) of plasma were transfused. The tumour was in the left adrenal gland. The course of this operation shows that the heart rate was well controlled in this adrenaline-producing tumour even when there was a very considerable rise of blood pressure as the tumour was handled. But when extensive haemorrhage occurred there was an immediate rise of heart rate.
Case 6
A 12-year-old schoolgirl complained of nausea during exertion when she went to Scotland on holiday, and a medically qualified relative heard an apical systolic murmur. Exercise tolerance had been reduced over the previous two years. She 
Discussion
The case reports cited above well exemplify the problems involved in the surgical removal of a phaeochromocytoma. These are not merely concerned with control of the blood pressure, which is subject to considerable elevation during induction of anaesthesia and to violent fluctuations during dissection of the tumour, with sudden fall after its removal. Equally important is control of the heart rate, which is determined by the type of amine secreted and may be increased by premedication and induction as well as by handling of the tumour and by loss of blood. Cardiac arrhythmias produced by sensitization of the myocardium to the anaesthetic agent by catecholamines are also a hazard. Hypovolaemia caused by long-continued arteriolar constriction intensifies the hypotensive effect of loss of blood. Each is discussed in turn.
Control of Blood Pressure before and during Operation
Most patients with a phaeochromocytoma respond to the ganglion-blocking drugs or to bretylium and guanethidine by a fall of blood pressure, though theoretically a rise of pressure might be anticipated, since these drugs potentiate the pressor effect when infused with noradrenaline in normal subjects (Geffen and Ross, 1956; Laurence and Nagle, 1963) . In practice this pressor effect seems to occur only with the intravenous administration of the hypotensive agents, and not when they are administered by mouth, presumably because the plasma concentration achieved is lower. These substances are not effective in controlling the blood pressure during removal of the tumour.
The hypothesis of a-and s-receptors put forward by Ahlquist (1948) to explain the differing actions of adrenaline and noradrenaline on various tissues suggested that a rational approach for the control of blood pressure and heart rate in this disease could be formulated. a-Receptors are responsible for vasoconstriction in all vascular beds, and hence their stimulation results in hypertension. a-Receptors mediate relaxation of arterial smooth muscle, and are also responsible for the inotropic and chronotropic effects of catecholamines on the myocardium (see Table) . Substances which block the a-receptors have been used for many years in this disease. Piperoxan hydrochloride (benzodioxane), dibenamine, tolazoline hydrochloride (Priscol, Priscoline), phentolamine (Rogitine, Regitine), and phenoxybenzamine (Dibenzyline, Dibenyline) have been used successively in the management of patients with phaeochromocytoma for the control of the blood pressure before and during operative removal of the tumour. Phentolamine is a short-acting blocking agent which must be given repeatedly by intravenous injection or by continuous infusion during handling of the tumour (Grimson, Longino, Kernodle, and O'Rear, 1949) . It abolishes some of the excessive swings of blood pressure, but control is far from perfect, as has been shown above. Despite the limitations of this drug its use is still advocated in recent papers (Glenn and Mannix, 1963 ; Crandell and Myers, 1964 ; Baker, Swindell, and Rollins, 1964; Kirkendall, Liechty, and Culp, 1965) .
Concept of Alpha
Phenoxybenzamine, on the other hand, has a much longer period of action and is much more effective in its clinical use. It may be given intravenously or orally. If full a-receptor blockade is required it is preferably given intravenously. Oral administration is satisfactory in the control of symptoms and blood pressure in patients awaiting operation or in whom the tumour cannot be found at laparotomy. For preoperative preparation we have given phenoxybenzamine intravenously. The dose was originally assessed on a weight basis, 1 mg./kg. body weight, following the recommendation of M. Nickerson (personal communication, 1960 ). In our most recent patients, when the tumour has been located before operation, 100 mg. of phenoxybenzamine has been given on each of three days immediately preceding operation, and 50 mg. on the morning of operation also seems desirable. When the tumour has not been located before operation less than complete a-receptor blockade is preferred, since location of the tumour is facilitated if a rise of blood pressure results from squeezing the tumour during surgical exploration of the abdominal cavity or thorax.
When complete antagonism of a-receptors is achieved the vascular compartment is fully dilated, so that the blood pressure is solely dependent upon cardiac output and blood volume. The blood pressure will therefore fall rapidly whenever bleeding occurs. The pressure will also fall if blood pools in the lower extremities. The patient must be warned of the liability to faint on standing, and should be kept in bed after phenoxybenzamine has been given intravenously.
Blood Pressure after Removal of the Tumour
Since the vascular compartment is fully expanded under the complete influence of adrenergic a-blocking agents, no fall of blood pressure results when catecholamines are no longer entering the circulation after clamping of venous effluent from the tumour and its removal. We have experienced no difficulty with hypotension from this cause in our patients. Hypotension in these circumstances denotes insufficient filling of the vascular system and is properly corrected by the administration of blood. Apprehension that antagonism of a-receptors would lead to irrecoverable hypotension after removal of the tumour (Crandell and Myers, 1964 ) is unfounded in practice.
If, by accident or by design, antagonism of a-receptors is incomplete there will be a fall of blood pressure when the tumour is removed, the extent of which will be determined by the degree of antagonism achieved and by the degree of filling of the circulation. Provided it is definite that hypovolaemia is not present, the blood pressure can be restored by the intravenous administration of noradrenaline, which will still be effective, as blockage of its receptors is incomplete. On These effects of the unopposed action of catecholamines on the /3-receptors can be blocked by dichloroisoprenaline (Moran and Perkins, 1958 ; Powell and Slater, 1958) , but this subutance itself has sympathomimetic activity. It has also been reported to cause myopathic changes in cat muscle (Zaimis, 1965) . It has been used successfully to control arrhythmias during operative removal of a -haeochromocytoma (Riddell et al., 1963) . Pronethalol has only slight sympathomimetic activity (Barrett, 1965) and has been demonstrated to be an effective /3-blocking agent in animals (Black and Stephenson, 1962 ; Black, Duncan, and Shanks, 1965) and in man (Dornhorst and Robinson, 1962) . It has unfortunately been incriminated as a carcinogen in mice, producing thymic and other tumours (Paget, 1963) , and has now been withdrawn.
Propranolol, so far as is known, is devoid of carcinogenic activity (Tucker, Alcock, and Baker, 1965) and has no intrinsic sympathomimetic activity (Black et al., 1965) . Clinically it is a more useful /3-receptor antagonist, as it has a much wider therapeutic ratio. It is given by mouth on the preoperative days when phenoxybenzamine is given. An initial dose of 20 mg. is given and the subsequent dosage is adjusted to produce the desired pulse rate; this may require as much as 120 mg. Propranolol can also be given intravenously, slowly, in doses of 1 to 5 mg. when the pulse rate rises during operation. This results not merely in a fall of heart rate but also usually in a rise of blood pressure (Prichard and Ross, 1966) .
Though this /0-receptor antagonist controls the tachycardia resulting from simultaneous blockage of adrenergic a-receptors, it should not be used to control the tachycardia of bleeding, which responds to adequate replacement by blood. It should be noted that the degree of /3-blockade which controls the tachycardia produced by a-blockade will reduce but not abolish the tachycardia of haemorrhage. Tachycardia therefore becomes a less sensitive indicator of the amount of blood loss in patients under adrenergic blockade.
Anaesthetic Agents
The hydrocarbon anaesthetic agents, such as cyclopropane, trichlorethylene, and halothane, stimulate the release of catecholamines from stores in tissues, including those in chromaffin tumours. Thiopentone does not have this action (Crandell and Myers, 1964) . In the case of cyclopropane this may occur with normal arterial Pco2 levels, but with halothane catecholamines increase only when there is CO2 retention (Black, Linde, Dripps, and Price, 1959) . These anaesthetic agents also sensitize the myocardium to the effects of catecholamines on excitation and conduction, leading to arrhythmias such as ventricular tachycardia, coupled beats, and multifocal extrasystoles.
Diethyl ether also releases catecholamines, and its administration often results in tachycardia, but not in ventricular arrhythmias. Thiopentone causes myocardial depression and hypotension. In the present series fall of blood pressure has followed the administration of thiopentone even though this has been injected slowly. This hypotensive phase has always been followed by a rebound of blood pressure above its original level.
When complete blockade of a-and P-receptors has been attempted a considerable fall of blood pressure may follow the administration of thiopentone-for example, when the patient (Case 7) was given 500 mg. of thiopentone his blood pressure fell from 110/76 to 60/? mm. Hg. Even the admin-BP MFDrCAI. JOURNAL istration of 125 mg. to another patient produced a fall from 100/70 to 70/?. Great care is therefore essential when anaesthesia is induced with thiopentone in the presence of /3-blocking agents.
Many of the problems in the management of patients witht phaeochromocytoma can be removed by the use of ether anaesthesia (Crandell and Myers, 1964) , but this precludes the use of cautery, and most surgeons prefer to have cautery available when removing these very vascular tumours.
Halothane has been used as an anaesthetic agent during this operation, but despite the use of phentolamine wide fluctuationss of blood pressure occurred (Murphy, Prior, and Joseph, 1964) . Etsten and Shimosato (1965) used halothane with controlled ventilation and showed that plasma levels of adrenaline and noradrenaline fell with the introduction of halothane and thatsqueezing the tumour did not provoke an excessive rise of pressor amines. Ventricular extrasystoles may occur with halothane anaesthesia if atropine is given in the presence of CO2 retention (Johnstone and Nisbeth, 1961) . Halothane may have a place in the anaesthetic management of these patients provided ventilation is adequate and monitoring of arterial Pco2 and venous pressure is performed.
Prevention of Arrhythmias
Adrenergic /-receptor antagonists protect the myocardium from the tendency of hydrocarbon anaesthetics and cardiac glycosides to produce arrhythmias and substantially increase the amounts of catecholamines or of hydrocarbon anaesthetic that can be given before arrhythmias appear (Schull, Berry, and Villarreal, 1961 ; Murray, McKnight, and Davis, 1963; Vaughan Williams and Sekiya, 1963) . Pronethalol is effective against ventricular arrhythmias (Harrison, Braunwald, Glick, Mason, Chidsey, and Ross, 1964; Cohen, Effat, Goodwin, Oakley, and Steiner, 1964) and has been used to protect against arrhythmias during operative removal of a phaeochromocytoma (Riddell et al., 1963) . Pronethalol antagonizes arrhythmias produced by cardiac glycosides (Stock and Dale, 1963; Vaughan Williams and Sekiya, 1963) . /3-Receptor antagonists must be used with caution in view of the report by Stock and Dale (1963) that heart failure can be precipitated by their administration. However, Gillam and Prichard (1965) report the case of a 71-year-old woman with angina in whom heart failure was precipitated by 10 mg. q.d.s. of propranolol by mouth. After treatment with digoxin and chlorothiazide she tolerated propranolol in a dose of 50 mg. q.d.s. without ill effect. Although we have given propranolol intravenously in a dose of 20 mg. repeated three times over a period of two hours in the preparation of a patient for laparotomy for postoperative intestinal obstruction (Prichard and Ross, 1966) Allen, 1942) and noradrenaline (Finnerty, Buchholz, and Guillaudeu, 1958) . Patients with a phaeochromocytoma may also have a reduced circulating plasma volume and sometimes also a reduced red-cell volume (Brunjes, Johns, and Crane, 1960) . This hypovolaemia is an important factor contributing to the hypotension that follows removal of the tumour in the patient not prepared preoperatively by adequate a-receptor blockade. Some authors recommend restoration of the blood volume by transfusion before operation, others during the early part of the operation. We follow the latter course, but also give phenoxybenzamine for three days before operation to permit circulatory readjustment to occur before operation.
Haemorrhage
Haemorrhage can be very considerable during removal of a large vascular tumour (the record size seems to be 3.6 kg. 
Adrenocortical Insufficiency
The possibility that the patient's sole adrenal gland may be removed with the phaeo' 'romocytoma is remote, but should be borne in mind when hypu.ension occurs without other obvious cause a week or more after operation. Hypotension due to adrenocortical insufficiency has occurred 10 days after an unsuccessful operation when the tumour had been incorrectly located by perirenal oxygen insufflation (Ross, 1961 
Conclusions a-Blockade
The advent of drugs which antagonize adrenergic a-receptors has greatly simplified the operative management of these tumours and has made it far less hazardous. The advantages of its use are: (1) preoperative vasodilatation, which permits re-expansion of the contracted plasma volume; (2) control of blood pressure and symptoms arising from this; it also has a soporific effect, so that the patient comes to the anaesthetic room placid and relaxed ; (3) the rise of blood pressure that follows induction of anaesthesia is reduced, as are the abrupt swings of blood pressure during handling and dissection of the tumour; and (4) since the patient no longer has a contracted circulating volume, removal of the tumour is not followed by an abrupt fall of blood pressure and it is unnecessary to infuse noradrenaline.
/3-Blockade /3-Blockade during the preoperative and operative management of patients with phaeochromocytoma appears to us to be indicated: (1) to control tachycardia, usually aggravated by a-blockade, and (2) when arrhythmlas are produced by a-blockade.
The administration of a /3-blocking agent to a patient under a-blockade causes a rise of blood pressure, which in turn necessitates administration of more a-blocker (Prichard and Ross, 1966) . Premedication and induction of anaesthesia in the patient under a-blockade can produce a serious increase in heart rate, which can be controlled by /3-blockade. It is desirable to test the patient's sensitivity to propranolol administered orally on the days before operation when an a-blocking agent has been given. The patient is given an appropriate dose of propranolol-for example, 40 mg.-when the premedication is given on the morning of operation.
During operation propranolol is given intravenously (5 mg. slowly over five minutes) if manipulation of the tumour produces tachycardia or arrhythmias.
Isoprenaline could, theoretically, be administered if /3-blockade has been excessive, as the blockade of propranolol is competitive.
Complete (or almost complete) blockade by both a-and /3-blocking agents appears to add difficulties to the surgical and anaesthetic management of the case in that (1) the patient becomes more sensitive to the hypotensive effect of thiopentone, which should be given slowly and in small dosage until the desired degree of anaesthesia is attained; (2) venous oozing is more pronounced when a-adrenergic agents are given, and this adds a hazard to the operative procedure; (3) Suggested Procedure in Patients with Persistent Hypertension 1. While awaiting operation hypertension should be controlled with oral phenoxybenzamine, and tachycardia with oral propranolol.
2. Day of operation minus three (D-3).-Phenoxybenzamine 1 mg./kg. given intravenously in 250 ml. of 5% glucose in water over a period of one hour. The blood pressure will usually fall, after a delay of 30 to 60 minutes, to about 110/70 mm. Hg. Blood pressure is taken at five-minute intervals during infusion and half-hourly thereafter. The patient must be confined to bed during this procedure.
3. D-2.-Repeat phenoxybenzamine as above. Two hours after phenoxybenzamine has been given administer propranolol, 40 mg. by mouth. Unless blood pressure is above 160/100 mm. Hg, phenoxybenzamine is not given. If the blood pressure is higher than this 50 mg. of phenoxybenzamine is given intravenously. If phenoxybenzamine has been given on the morning of operation half the dose of propranolol previously required to lower the pulse rate to 80 beats per minute is administered. If no phenoxybenzamine has been given one-quarter of the dose of propranolol is given, provided the pulse rate is 100 or more. For pulse rates between 90 and 100 one-eighth of the dose is given. If less than 90 no propranolol preoperatively is recommended.
6. During operation.-Arterial pressure and pulse rate are recorded at two-minute intervals. An E.C.G. monitor is run continuously and frequent measurements are made of central venous pressure. Two intravenous infusions are set up. A supply of the following drugs for intravenous use must be available in the theatre: phentolamine, noradrenaline (8M./ml.), hydrocortisone, propranolol, sodium bicarbonate, and isoprenaline.
Summar
The high mortality of surgical removal of a phaeochromocytoma prompted the use of adrenergic blocking agents in preoperative and operative management. This paper details experience with the use of various a-and /2-adrenergic blocking agents in 27 patients.
The short duration of action of phentolamine and the tachycardia it produces limits its usefulness as an a-blocker, and preference is given to phenoxybenzamine. This drug is given intravenously nor three days before operation to control blood pressure and enable the blood volume to re-expand. Removal of the tumour is not promptly followed by hypotension provided a-blockade is adequate and blood loss is replaced. The use of noradrenaline is thereby avoided.
Tachycardia and arrhythmias are controlled by 3-blockers given orally preoperatively, and intravenously with caution during operation. Initially pronethalol was used, but this has been superseded by propranolol. Complete a-and /-blockade is not advocated, and /3-blockade must not be used without previous administration of an a-blocking agent.
Dangers of anaesthesia are outlined, especially the hypotensive effect of thiopentone in the presence of adrenergic blockade and the occurrence of arrhythmias with hydrocarbon anaesthetic agents. The response to haemorrhage is modified by these drugs; frequent arterial and venous pressure measurements and E.C.G. monitoring are essential for adequate blood replacement and prevention of overtransfusion.
A suggested procedure for the management of these patients is outlined.
Removal of a phaeochromocytoma still remains a potentially hazardous procedure, and its success depends largely upon the harmonious co-operation of a team comprising physician, pharmacologist, anaesthetist, and surgeon.
